LM
REPL icon

Luminus Management’s Replimune Group REPL Stock Holding History

Luminus Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,796
Closed -$158K – 29
2022
Q4 		$158K Buy
+5,796
New +$120K 0.04% 20

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Luminus Management's REPL Position: Q1 2023 in Review

Luminus Management sold out of Replimune Group (REPL) in Q1 2023, closing a stake of 5,796 shares — an estimated $158K sold.

Luminus Management first reported a position in REPL in Q4 2022 and held it in 1 quarter. The position peaked at $158K in Q4 2022. 140 funds tracked by Wall St. Rank hold REPL as of Q1 2023.

  • Luminus Management reported no remaining Replimune Group position as of Q1 2023 after selling out during the quarter.
  • Luminus Management sold 5,796 Replimune Group shares in Q1 2023, an estimated $158K.
  • Luminus Management first reported a position in Replimune Group in Q4 2022 and held it in 1 quarter.
  • Luminus Management's Replimune Group position peaked at $158K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q1 2023.

Based on Luminus Management's 13F filing for Q1 2023, filed 15 May 2023.